|
US4599152A
(en)
|
1985-05-24 |
1986-07-08 |
Albion Laboratories |
Pure amino acid chelates
|
|
US4863898A
(en)
|
1986-02-06 |
1989-09-05 |
Albion International, Inc. |
Amino acid chelated compositions for delivery to specific biological tissue sites
|
|
US4883658A
(en)
|
1986-04-28 |
1989-11-28 |
Holly Frank J |
Ophthalmic solution for treatment of dry-eye syndrome
|
|
US4804539A
(en)
|
1986-07-28 |
1989-02-14 |
Liposome Technology, Inc. |
Ophthalmic liposomes
|
|
US4914088A
(en)
|
1987-04-02 |
1990-04-03 |
Thomas Glonek |
Dry eye treatment solution and method
|
|
US5278151A
(en)
|
1987-04-02 |
1994-01-11 |
Ocular Research Of Boston, Inc. |
Dry eye treatment solution
|
|
US5061815A
(en)
|
1988-07-06 |
1991-10-29 |
Zinpro Corporation |
Metal lysine complexes and method for producing metal lysine complexes
|
|
US5075104A
(en)
|
1989-03-31 |
1991-12-24 |
Alcon Laboratories, Inc. |
Ophthalmic carboxy vinyl polymer gel for dry eye syndrome
|
|
ZA912797B
(en)
|
1990-05-29 |
1992-12-30 |
Boston Ocular Res |
Dry eye treatment process and solution
|
|
EP0459148B1
(en)
|
1990-05-29 |
1996-01-03 |
Ocular Research Of Boston Inc. |
Dry eye treatment composition
|
|
ZA927277B
(en)
|
1991-10-02 |
1993-05-19 |
Boston Ocular Res |
Dry eye treatment process and solution.
|
|
US6048897A
(en)
|
1993-06-15 |
2000-04-11 |
Brigham And Women's Hospital |
Lipoxin compounds and their use in treating cell proliferative disorders
|
|
US5441951A
(en)
|
1994-06-15 |
1995-08-15 |
Brigham & Women's Hospital |
Lipoxin compounds
|
|
US6887901B1
(en)
|
1993-06-15 |
2005-05-03 |
Brigham & Women's Hospital, Inc. |
Lipoxin compounds and their use in treating cell proliferative disorders
|
|
IT1264987B1
(it)
|
1993-12-14 |
1996-10-17 |
Prospa Bv |
Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono
|
|
US5795909A
(en)
|
1996-05-22 |
1998-08-18 |
Neuromedica, Inc. |
DHA-pharmaceutical agent conjugates of taxanes
|
|
FR2774591B1
(fr)
|
1998-02-12 |
2000-05-05 |
Lipha |
Composition pharmaceutique comprenant l'association metformine et fibrate et son utilisation pour la preparation de medicaments destines a reduire l'hyperglycemie
|
|
ATE269069T1
(de)
|
1998-04-29 |
2004-07-15 |
Sumitomo Pharma |
Orale zubereitung enthaltend einen biguanid und eine organische säure
|
|
JP4526622B2
(ja)
|
1998-10-23 |
2010-08-18 |
北興化学工業株式会社 |
農園芸用種子消毒剤および種子の消毒方法
|
|
JP2000212145A
(ja)
|
1999-01-22 |
2000-08-02 |
Hokko Chem Ind Co Ltd |
Ｎε―アシル―４―オキサリジンおよびその製造用中間体
|
|
US6720001B2
(en)
|
1999-10-18 |
2004-04-13 |
Lipocine, Inc. |
Emulsion compositions for polyfunctional active ingredients
|
|
WO2001056562A1
(en)
|
2000-02-04 |
2001-08-09 |
Takeda Chemical Industries, Ltd. |
Stable emulsion compositions
|
|
EP1762557B1
(en)
|
2000-02-16 |
2011-04-06 |
The Brigham And Women's Hospital, Inc. |
Aspirin-triggered lipid mediators
|
|
US6491950B1
(en)
|
2000-08-07 |
2002-12-10 |
Kos Pharmaceuticals, Inc. |
Controlled release pharmaceutical composition
|
|
US6667064B2
(en)
|
2000-08-30 |
2003-12-23 |
Pilot Therapeutics, Inc. |
Composition and method for treatment of hypertriglyceridemia
|
|
US6689385B2
(en)
|
2000-11-03 |
2004-02-10 |
Chronorx Llc |
Formulations for the treatment of insulin resistance and type 2 diabetes mellitus
|
|
DE10102050A1
(de)
|
2001-01-17 |
2002-07-18 |
Basf Ag |
Zubereitung zur Verbesserung der Nahrungsverwertung
|
|
DE60229640D1
(de)
|
2001-03-02 |
2008-12-11 |
Brigham & Womens Hospital |
Lipoxin analoge als neue inhibitoren der angiogenese
|
|
WO2002079139A1
(de)
|
2001-03-29 |
2002-10-10 |
Basf Aktiengesellschaft |
Konjugierte ungesättigte glyceridgemische und verfahren zur ihrer herstellung
|
|
DE60234780D1
(de)
|
2001-08-31 |
2010-01-28 |
Univ Rutgers |
Verfahren zur behandlung von krankheiten mit pflanzenextrakten
|
|
EP1441715B1
(en)
|
2001-11-06 |
2013-02-27 |
The Brigham And Women's Hospital, Inc. |
Lipoxins and aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases
|
|
ITMI20012384A1
(it)
|
2001-11-12 |
2003-05-12 |
Quatex Nv |
Uso di acidi grassi poliinsaturi per la prevenzione primaria di eventi cardiovascolari maggiori
|
|
AU2003211131A1
(en)
|
2002-02-14 |
2003-09-04 |
Sonus Pharmaceuticals, Inc. |
Metformin salts of lipophilic acids
|
|
US7670612B2
(en)
|
2002-04-10 |
2010-03-02 |
Innercap Technologies, Inc. |
Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
|
|
EP1549352A4
(en)
|
2002-05-06 |
2005-07-27 |
Nucleonics Inc |
METHOD OF DISTRIBUTING NUCLEIC ACIDS
|
|
ATE382597T1
(de)
|
2002-06-17 |
2008-01-15 |
Resolvyx Pharmaceuticals |
Analoga von omega-3-pufas abgeleiteten lipidmediatoren und anwendungsverfahren
|
|
WO2004004693A1
(en)
|
2002-07-05 |
2004-01-15 |
Collgegium Pharmaceutical |
Abuse-deterrent pharmaceutical compositions of opiods and other drugs
|
|
US7214387B2
(en)
|
2002-08-02 |
2007-05-08 |
Penwest Pharmaceuticals Company |
Sustained release formulations of metformin
|
|
US7759395B2
(en)
|
2002-08-12 |
2010-07-20 |
The Brigham And Women's Hospital, Inc. |
Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma
|
|
BR0314799A
(pt)
|
2002-09-27 |
2005-07-26 |
Market Biosciences Corp |
Controle glicêmico aperfeiçoado para pré-diabetes e/ou diabetes do tipo ii usando ácido docosahexaenóico
|
|
US7547454B2
(en)
|
2002-11-07 |
2009-06-16 |
Shyam K Gupta |
Hydroxy acid complexes for antiaging and skin renovation
|
|
JP2004175790A
(ja)
|
2002-11-12 |
2004-06-24 |
Arita Junichi |
α−グルコシダーゼ阻害作用を有する亜鉛含有物
|
|
ITMI20022394A1
(it)
|
2002-11-13 |
2004-05-14 |
Bracco Spa |
Uso di triiodotironina 3-solfato come farmaco ad attivita' tireomimetica e relative formulazioni farmaceutiche.
|
|
RU2356247C2
(ru)
|
2003-03-18 |
2009-05-27 |
Новартис Аг |
Комбинации и композиции, содержащие жирные кислоты и аминокислоты, их применение для предупреждения, замедления прогрессирования или лечения диабета и связанных с диабетом заболеваний и состояний, способ снижения веса тела млекопитающего, набор
|
|
EP1624858B1
(en)
|
2003-04-09 |
2018-06-06 |
Rutgers, the State University of New Jersey |
Novel encochleation methods
|
|
EP1510208A1
(en)
|
2003-08-22 |
2005-03-02 |
Fournier Laboratories Ireland Limited |
Pharmaceutical composition comprising a combination of metformin and statin
|
|
US20080045559A1
(en)
|
2003-10-29 |
2008-02-21 |
Sonus Pharmaceuticals, Inc. |
Tocopherol-modified therapeutic drug compounds
|
|
AU2004285037B2
(en)
|
2003-10-29 |
2010-07-22 |
Sonus Pharmaceuticals, Inc. |
Tocopherol-modified therapeutic drug compounds
|
|
JP2007509975A
(ja)
|
2003-10-31 |
2007-04-19 |
アルザ・コーポレーシヨン |
ギャバペンチン及びプレギャバリンの増加された吸収のための組成物及び投与形態物
|
|
CA2554617A1
(en)
|
2004-01-22 |
2005-08-04 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an n-methyl-d-aspartate (nmda) receptors antagonist
|
|
GB0403247D0
(en)
|
2004-02-13 |
2004-03-17 |
Tillotts Pharma Ag |
A pharmaceutical composition
|
|
EP1591114A1
(en)
|
2004-03-12 |
2005-11-02 |
Fournier Laboratories Ireland Limited |
Use of metformin and orlistat for the treatment or prevention of obesity
|
|
US20060003976A1
(en)
|
2004-06-04 |
2006-01-05 |
Yuehua Zhang |
Cholesterol/bile acid/bile acid derivative-modified therapeutic drug compounds
|
|
TWI236573B
(en)
|
2004-07-09 |
2005-07-21 |
Asia Optical Co Inc |
Camera lens with adjustment mechanism
|
|
CN101094683A
(zh)
|
2004-10-29 |
2007-12-26 |
J·坎贝尔－托夫特 |
从催吐萝芙木和酸橙中分离的抗糖尿病提取物及其使用方法
|
|
US20060293288A1
(en)
|
2005-01-07 |
2006-12-28 |
Serhan Charles N |
Use of resolvins to treat gastrointestinal diseases
|
|
EP1888728A4
(en)
|
2005-05-04 |
2010-07-14 |
Pronova Biopharma Norge As |
Fatty acid analogues, D.H. DHA DERIVATIVES FOR USE AS A MEDICAMENT
|
|
AU2006264407B2
(en)
|
2005-07-04 |
2012-08-30 |
Ramu Krishnan |
Improved drug or pharmaceutical compounds and a preparation thereof
|
|
WO2007041440A2
(en)
*
|
2005-10-03 |
2007-04-12 |
The Brigham And Women's Hospital, Inc. |
Anti-inflammatory actions of neuroprotectin d1/protectin d1 and its natural stereoisomers
|
|
WO2007056281A2
(en)
|
2005-11-03 |
2007-05-18 |
Ilypsa, Inc. |
Multivalent indole compounds and use thereof as phospholipase-a2 inhibitors
|
|
JP2009526747A
(ja)
|
2006-02-16 |
2009-07-23 |
武田薬品工業株式会社 |
環状アミン化合物および高血圧の予防・治療のための用途
|
|
US20090047340A1
(en)
|
2006-03-29 |
2009-02-19 |
Guilford F Timothy |
Liposomal reduced glutathione and 1-arginine, including with other ingredient(s), capable of multipath administration for reversal and prevention of obesity and for mitochondrial biogenesis
|
|
US7973073B2
(en)
|
2006-06-16 |
2011-07-05 |
Indigene Pharmaceuticals, Inc. |
Antidiabetic agent for control of diabetic hyperglycemia and diabetic complications
|
|
US20120189569A1
(en)
|
2006-08-06 |
2012-07-26 |
Bioderm Research |
Hydroxy Acid Complexes for Skin Renovation and Clarity
|
|
TW200816991A
(en)
*
|
2006-08-23 |
2008-04-16 |
Bayer Schering Pharma Ag |
Treatment and prevention of intestinal fibrosis
|
|
JP5552313B2
(ja)
|
2006-11-01 |
2014-07-16 |
プロノヴァ・バイオファーマ・ノルゲ・アーエス |
脂質化合物
|
|
WO2008058274A2
(en)
|
2006-11-09 |
2008-05-15 |
Children's Medical Center Corporation |
Use of resolvins and docosatrienes and analogues thereof for the treatment of angiogenesis and ocular neovascularization
|
|
PE20120395A1
(es)
*
|
2006-12-04 |
2012-05-23 |
Bayer Ip Gmbh |
Sal de potasio cristalina de analogos de lipoxina a4
|
|
EP2109447B1
(en)
|
2007-01-29 |
2015-06-10 |
HanAll Biopharma Co., Ltd. |
N, n- dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same
|
|
WO2008139941A1
(en)
|
2007-04-27 |
2008-11-20 |
Takeda Pharmaceutical Company Limited |
Substituted imidazole compound and use thereof
|
|
US20090227560A1
(en)
|
2007-04-27 |
2009-09-10 |
Takanobu Kuroita |
Substituted imidazole compound and use thereof
|
|
US20090054513A1
(en)
|
2007-08-22 |
2009-02-26 |
Response Scientific, Inc. |
Method of managing blood glucose levels, insulin levels and/or insulin receptor functionality in individuals with diabetes, polycystic ovarian syndrome and/or alzheimer's disease
|
|
EP2203418B1
(en)
|
2007-09-21 |
2017-10-25 |
HanAll Biopharma Co., Ltd. |
N,n-dimethyl imidodicarbonimidic diamide dicarboxylate, method for producing the same and pharmaceutical compositions comprising the same
|
|
JP5441705B2
(ja)
|
2007-10-15 |
2014-03-12 |
武田薬品工業株式会社 |
アミド化合物およびその用途
|
|
AU2009245294B2
(en)
|
2008-05-05 |
2014-02-20 |
Oramed Ltd. |
Methods and compositions for oral administration of exenatide
|
|
JP4800445B2
(ja)
|
2008-06-19 |
2011-10-26 |
武田薬品工業株式会社 |
複素環化合物およびその用途
|
|
HRP20140194T1
(hr)
|
2008-06-26 |
2014-06-20 |
Laboratorios Silanes, S.A. De C.V. |
Nova sol metformin glicinat za kontrolu glukoze u krvi
|
|
FR2934519B1
(fr)
|
2008-08-01 |
2013-06-28 |
Oreal |
Procede de fabrication d'un premier recipient de produit cosmetique, moule, col et recipient associes
|
|
EP4008327A1
(en)
|
2009-04-29 |
2022-06-08 |
Amarin Pharmaceuticals Ireland Limited |
Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
|
|
EP3318255B1
(en)
|
2009-06-15 |
2021-03-10 |
Amarin Pharmaceuticals Ireland Limited |
Compositions and methods for treating stroke in a subject on concomitant statin therapy
|
|
WO2011034887A2
(en)
|
2009-09-15 |
2011-03-24 |
The Brigham And Women's Hospital, Inc. |
A method for treating neuropathic pain
|
|
PL217815B1
(pl)
|
2009-12-14 |
2014-08-29 |
Olimp Lab Spółka Z Ograniczoną Odpowiedzialnością |
Napój izotoniczny z chelatami
|
|
US8178707B2
(en)
|
2010-03-25 |
2012-05-15 |
Jost Chemical Company |
Co-precipitated salts of fatty acids
|
|
US20110052678A1
(en)
|
2010-11-05 |
2011-03-03 |
Shantha Totada R |
Method for treating age related macular degeneration
|
|
US8796338B2
(en)
|
2011-01-07 |
2014-08-05 |
Elcelyx Therapeutics, Inc |
Biguanide compositions and methods of treating metabolic disorders
|
|
US20120178813A1
(en)
|
2011-01-12 |
2012-07-12 |
Thetis Pharmaceuticals Llc |
Lipid-lowering antidiabetic agent
|
|
KR20180100455A
(ko)
|
2011-04-13 |
2018-09-10 |
아지노모토 가부시키가이샤 |
영양 조성물
|
|
LT2800563T
(lt)
|
2012-01-06 |
2018-10-25 |
Omthera Pharmaceuticals Inc. |
Laisvos rūgšties formos omega-3 polinesočiųjų riebalų rūgščių dpa praturtintos kompozicijos
|
|
JP2015511012A
(ja)
|
2012-03-06 |
2015-04-13 |
ライフ テクノロジーズ コーポレーション |
全身性エリテマトーデスのためのバイオマーカー
|
|
ES2946109T3
(es)
|
2012-05-10 |
2023-07-12 |
Solutex Na Llc |
Aceites con actividad antiinflamatoria que contienen mediadores pro-resolutivos especializados naturales y sus precursores
|
|
CA2916208A1
(en)
|
2012-06-17 |
2013-12-27 |
Matinas Biopharma, Inc. |
Omega-3 pentaenoic acid compositions and methods of use
|
|
US20140011814A1
(en)
|
2012-07-06 |
2014-01-09 |
Thetis Pharmaceuticals Llc |
Diamine and meglumine salt forms of fatty acids
|
|
EP2872483A4
(en)
|
2012-07-10 |
2016-03-16 |
Thetis Pharmaceuticals Llc |
THREE METFORMIN SALT FORM
|
|
US8765811B2
(en)
|
2012-07-10 |
2014-07-01 |
Thetis Pharmaceuticals Llc |
Tri-salt form of metformin
|
|
WO2014011895A2
(en)
|
2012-07-11 |
2014-01-16 |
Thetis Pharmaceuticals Llc |
High solubility acid salts, intravenous dosage forms, nutrition supplementation and methods of use thereof
|
|
AU2012227298B2
(en)
|
2012-09-25 |
2015-02-12 |
Jost Chemical Co. |
Co-precipitated salts of fatty acids
|
|
TW201416726A
(zh)
|
2012-10-26 |
2014-05-01 |
Dongguan Masstop Liquid Crystal Display Co Ltd |
具有觸控功能之彩色濾光片基板
|
|
US9394318B2
(en)
|
2012-11-30 |
2016-07-19 |
Cypress Pharmaceuticals, Inc. |
Crystal polymorph of magnesium glycinate dihydrate and process for its preparation
|
|
CN103340300A
(zh)
|
2013-06-06 |
2013-10-09 |
李才平 |
一种绿色生态鲫鱼饲料的配制方法
|
|
CA2947741A1
(en)
|
2014-05-05 |
2015-11-12 |
Thetis Pharmaceuticals Llc |
Compositions and methods relating to ionic salts of peptides
|
|
US9242008B2
(en)
*
|
2014-06-18 |
2016-01-26 |
Thetis Pharmaceuticals Llc |
Mineral amino-acid complexes of fatty acids
|
|
BR112016029476A2
(pt)
*
|
2014-06-18 |
2017-08-22 |
Thetis Pharmaceuticals Llc |
complexos de aminoácido mineral de agentes ativos
|
|
CN104430341B
(zh)
|
2014-12-10 |
2016-09-28 |
青岛大学 |
天然有机酸根褐藻氨酸螯合物在农用制剂中的应用
|
|
US10653703B2
(en)
|
2015-09-03 |
2020-05-19 |
Solutex Na Llc |
Compositions comprising omega-3 fatty acids, 17-HDHA and 18-HEPE and methods of using same
|
|
GB201522132D0
(en)
|
2015-12-15 |
2016-01-27 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
US10130719B2
(en)
|
2016-06-03 |
2018-11-20 |
Thetis Pharmaceuticals Llc |
Compositions and methods relating to salts of specialized pro-resolving mediators
|